TrialBreast cancer research : BCR2006

Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835].

Vasso Apostolopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.